Retrospective clinical evaluation of a novel medical technology (Mia™)
Research type
Research Study
Full title
Retrospective clinical evaluation of a novel medical technology (Mia™) on Scottish Breast Screening cases
IRAS ID
277460
Contact name
Gerald Lip
Contact email
Sponsor organisation
Kheiron Medical Technologies
Duration of Study in the UK
1 years, 8 months, 31 days
Research summary
Breast cancer is one of the most frequently occurring cancer types in women worldwide. Breast cancer screening is considered to be the world-wide gold standard for early detection and control of breast cancer. Given the recent workforce crisis in radiology, increasing diagnostic demands, and the challenge of detecting malignant mammographic features in screening, many sites struggle to meet required diagnostic performance targets as radiologists miss about every 5th to 7th cancer, and approximately 90% of patients are called back when having no malignancy. Radiologists currently have no effective practical support tools for reading mammography images.
The aim of this study is to evaluate how well Mia™ performs on screening cases from the Scottish
Breast Screening Programme, a programme that has been independent from the development of the solution to date. Mia™ or ‘Mammography intelligent assessment’ is an automated deep learning tool that assesses mammograms taken in a screening setting and makes a case-wise decision on whether or not further investigation is needed (recall decision). The aims are to help radiologist decision-making, reduce workflow burden, and reduce the false positive rate for cancer detection in current screening systems.REC name
London - Bloomsbury Research Ethics Committee
REC reference
20/LO/0563
Date of REC Opinion
22 Apr 2020
REC opinion
Favourable Opinion